Hypera Stock

Hypera EBIT Growth

The Year-over-Year EBIT Growth of Hypera (HYPE3.SA) as of Aug 16, 2026 is -0.34 %. In the previous year, Year-over-Year EBIT Growth was -14.66 % — a change of -97.71% (higher).

EBIT Growth

-0.34 %

YoY

-97.71%

Last updated:

Year-over-Year EBIT Growth of Hypera is 2026 -0.34 % . Year-over-Year EBIT Growth of Hypera was 2025 -14.66 % . It decreases by -97.71% higher compared to the previous year.
Access this data via the Eulerpool API

Hypera Stock analysis

What does Hypera do? Hypera SA is a Brazilian pharmaceutical company founded in 2001, specializing in the development, production, and distribution of drugs, generics, medical devices, and cosmetic products primarily for the Brazilian healthcare industry. Hypera is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hypera stock

Year-over-Year EBIT Growth of Hypera is -0.34 % in 2026.

On Eulerpool you can find the complete historical development of Year-over-Year EBIT Growth Hypera since 2006 – with annual values, charts, and detailed analysis.

EBIT growth measures the percentage change in operating earnings. It shows whether a company's core operations are becoming more profitable.

To evaluate Year-over-Year EBIT Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBIT Growth.

Year-over-Year EBIT Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBIT Growth's Hypera historically and in real time.

Access this data via the Eulerpool API

Growth — Hypera

All Key Metrics — Hypera